RobertJYoungMD

Radiology • New York, NY

Neuroradiology

Attending, Neuroradiology Service; Director of Brain Imaging; Director of Neuroradiology Research; Co-Chair of MRI Committee

Join to view full profile

Dr. Young is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Young's full profile

Already have an account?

Office
Memorial Sloan Kettering Cancer Center
1275 York Avenue
New York, NY 10065
Phone+1 212-639-8196

Education & Training

NYU Grossman School of MedicineFellowship, Neuroradiology, 2004 - 2006
Icahn School of Medicine at Mount Sinai (West)Residency, Radiology-Diagnostic, 2000 - 2004
New York-Presbyterian/QueensInternship, Internal Medicine, 1999 - 2000
SUNY Upstate Medical UniversityClass of 1999

Certifications & Licensure

NY State Medical License 2000 - 2026
NJ State Medical License 2007 - 2025
American Board of Radiology Diagnostic Radiology
American Board of Radiology Neuroradiology

Clinical Trials

Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors Start of enrollment: 2009 Mar 01
Recruiting
Not Applicable
MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning Start of enrollment: 2012 Feb 01
Completed
Not Applicable
A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression Start of enrollment: 2012 May 01
Completed
Not Applicable
Functional Imaging of Cerebellar Mutism Syndrome Start of enrollment: 2012 Nov 01
Completed
PET and MRI Imaging of Brain Tumors Using [18F]PARPi Start of enrollment: 2019 Nov 01
Active, not recruiting
Join now to see all

Publications & Presentations

PubMed

Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumab.
Sarah E Lochrin, Darren J Buonocore, Robert J Young, Thomas J Kaley, Michael A Postow
Pigment Cell & Melanoma Research. 2024-11-01
2 citations
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of I...
Martin J van den Bent, Pim J French, Daniel Brat, Joerg C Tonn, Mehdi Touat
Neuro-Oncology. 2024-10-03
4 citations
Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future ...
Jessica A Wilcox, Ugonma N Chukwueke, Myung-Ju Ahn, Ayal A Aizer, Tejus A Bale
Neuro-Oncology. 2024-10-03

Journal Articles

Efficacy of MEK Inhibition in Patients with Histiocytic Neoplasms
Robert J Young, Mario Lacouture, Neal Rosen, David M Hyman, Raajit Rampal, Gary A Ulaner, Benjamin H Durham, Lynn A Brody, Nature